143 related articles for article (PubMed ID: 20955413)
21. IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation.
Yamaguchi S; Iwanaga E; Tokunaga K; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N
Eur J Haematol; 2014 Jun; 92(6):471-7. PubMed ID: 24443894
[TBL] [Abstract][Full Text] [Related]
22. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.
Abbas S; Lugthart S; Kavelaars FG; Schelen A; Koenders JE; Zeilemaker A; van Putten WJ; Rijneveld AW; Löwenberg B; Valk PJ
Blood; 2010 Sep; 116(12):2122-6. PubMed ID: 20538800
[TBL] [Abstract][Full Text] [Related]
23. Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.
Zhou KG; Jiang LJ; Shang Z; Wang J; Huang L; Zhou JF
Leuk Lymphoma; 2012 Dec; 53(12):2423-9. PubMed ID: 22616558
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients.
Aref S; Kamel Areida el S; Abdel Aaal MF; Adam OM; El-Ghonemy MS; El-Baiomy MA; Zeid TA
Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):550-5. PubMed ID: 26189213
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms.
Molenaar RJ; Thota S; Nagata Y; Patel B; Clemente M; Przychodzen B; Hirsh C; Viny AD; Hosano N; Bleeker FE; Meggendorfer M; Alpermann T; Shiraishi Y; Chiba K; Tanaka H; van Noorden CJ; Radivoyevitch T; Carraway HE; Makishima H; Miyano S; Sekeres MA; Ogawa S; Haferlach T; Maciejewski JP
Leukemia; 2015 Nov; 29(11):2134-42. PubMed ID: 25836588
[TBL] [Abstract][Full Text] [Related]
26. The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia.
Chou WC; Lei WC; Ko BS; Hou HA; Chen CY; Tang JL; Yao M; Tsay W; Wu SJ; Huang SY; Hsu SC; Chen YC; Chang YC; Kuo KT; Lee FY; Liu MC; Liu CW; Tseng MH; Huang CF; Tien HF
Leukemia; 2011 Feb; 25(2):246-53. PubMed ID: 21079611
[TBL] [Abstract][Full Text] [Related]
27. Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia.
Ashraf S; Noguera NI; Di Giandomenico J; Zaza S; Hasan SK; Lo-Coco F
Ann Hematol; 2013 Oct; 92(10):1319-23. PubMed ID: 23949315
[TBL] [Abstract][Full Text] [Related]
28. Characterization of NPM1, FLT3, and IDH1 mutations in adult patients with acute myeloid leukemia: a Brazilian cohort study.
Cruz NG; Ribeiro AF; Glória AB; Abbas S; Assumpção JG; Santos SM; Rezende SM; Xavier SG; Fagundes EM
Leuk Lymphoma; 2016 Dec; 57(12):2901-2904. PubMed ID: 27071442
[No Abstract] [Full Text] [Related]
29. The importance of plasma D-2HG measurement in screening for IDH mutations in acute myeloid leukaemia.
McGehee E; Rakheja D; Oliver D; Chen W; Boriack R; Collins RH
Br J Haematol; 2016 Apr; 173(2):323-6. PubMed ID: 26195003
[No Abstract] [Full Text] [Related]
30. Case series of patients with acute myeloid leukemia receiving hypomethylation therapy and retrospectively found to have IDH1 or IDH2 mutations.
Benton CB; Ravandi F; Andreeff M; Kadia T; Ruvolo V; Qiu P; Wheeler DA; Garcia-Manero G; Cortes J; Kantarjian HM; Konopleva M
Leuk Lymphoma; 2014 Jun; 55(6):1431-4. PubMed ID: 24033106
[No Abstract] [Full Text] [Related]
31. [Clinical characteristics in adult acute myeloid leukemia with isocitrate dehydrogenase gene mutation].
Wang RX; Wu DP; Chen SN; He J; Xu Y; Wang XL; Yin J; Tian H; Tian XP; Sun AN
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):751-5. PubMed ID: 23755812
[TBL] [Abstract][Full Text] [Related]
32. Persistent
Ok CY; Loghavi S; Sui D; Wei P; Kanagal-Shamanna R; Yin CC; Zuo Z; Routbort MJ; Tang G; Tang Z; Jorgensen JL; Luthra R; Ravandi F; Kantarjian HM; DiNardo CD; Medeiros LJ; Wang SA; Patel KP
Haematologica; 2019 Feb; 104(2):305-311. PubMed ID: 30171025
[TBL] [Abstract][Full Text] [Related]
33. Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents.
DiNardo CD; Patel KP; Garcia-Manero G; Luthra R; Pierce S; Borthakur G; Jabbour E; Kadia T; Pemmaraju N; Konopleva M; Faderl S; Cortes J; Kantarjian HM; Ravandi F
Leuk Lymphoma; 2014 Aug; 55(8):1925-9. PubMed ID: 24138309
[No Abstract] [Full Text] [Related]
34. Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm.
Issa GC; DiNardo CD
Blood Cancer J; 2021 Jun; 11(6):107. PubMed ID: 34083508
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations.
Shoukier M; Kadia T; Konopleva M; Alotaibi AS; Alfayez M; Loghavi S; Patel KP; Kanagal-Shamanna R; Cortes J; Samra B; Jabbour E; Garcia-Manero G; Takahashi K; Pierce S; Short NJ; Yilmaz M; Sasaki K; Masarova L; Pemmaraju N; Borthakur G; Kantarjian HM; Ravandi F; DiNardo CD; Daver N
Cancer; 2021 Feb; 127(3):381-390. PubMed ID: 33119202
[TBL] [Abstract][Full Text] [Related]
36. Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia.
Koszarska M; Bors A; Feczko A; Meggyesi N; Batai A; Csomor J; Adam E; Kozma A; Orban TI; Lovas N; Sipos A; Karaszi E; Dolgos J; Fekete S; Reichardt J; Lehoczky E; Masszi T; Tordai A; Andrikovics H
Leuk Lymphoma; 2013 May; 54(5):1028-35. PubMed ID: 23039322
[TBL] [Abstract][Full Text] [Related]
37. Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro.
Sarkaria SM; Christopher MJ; Klco JM; Ley TJ
Leukemia; 2014 Dec; 28(12):2403-6. PubMed ID: 25092143
[No Abstract] [Full Text] [Related]
38. Correlation between IDH2 mutations and disease status in acute myeloid leukemia.
Eklund EA; Raychaudhuri P; Platanias LC
Leuk Lymphoma; 2010 Dec; 51(12):2157-8. PubMed ID: 20929316
[No Abstract] [Full Text] [Related]
39. Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies.
Horbinski C; Kelly L; Nikiforov YE; Durso MB; Nikiforova MN
J Mol Diagn; 2010 Jul; 12(4):487-92. PubMed ID: 20431032
[TBL] [Abstract][Full Text] [Related]
40. [Detection of the IDH1 gene mutation in acute myeloid leukemia by PCR-high resolution melting analysis].
Lin J; Qian J; Yao DM
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):484-6. PubMed ID: 22213873
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
